News

Sira Medical Wins FDA Clearance for Augmented Reality Preoperative Surgical Planning Software

The U.S. Food and Drug Administration granted Sira Medical clearance for its augmented reality preoperative surgical planning application, which provides clinicians with advanced imaging to assist in making key patient management decisions.

Nested Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for NST-628, a Novel Pan-RAF/MEK Molecular Glue

Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) cleared the investigational new drug (IND) application for NST-628 for the treatment of patients...

J&J and Trial Library expand partnership on recruitment tools aimed at diversity

Johnson & Johnson Innovative Medicine and Trial Library have expanded a partnership to integrate the latter's clinical trial discovery platform into the pharma’s oncology clinical development and medical affairs programs. In a March 21 press release about the development, Trial Library CEO and...

Siolta Therapeutics Raises $12 Million in Series C Financing for Clinical Development

Siolta Therapeutics, a clinical-stage biotech company, has announced the completion of a $12 million Series C financing round. The round, co-led by SymBiosis and Khosla Ventures, reflects enthusiasm for Siolta's approach to developing live microbiome-based therapeutics and involved all existing...

Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders

Turbocharged CAR-T cells melt tumours in mice — using a trick from cancer cells

Immune cells armed with a mutation first identified in cancer cells gain potency but don’t turn cancerous themselves. “Natural T-cell function isn’t good enough. We need to explore the extremes of T-cell function,” says Kole Roybal, an immunologist at the University of California, San Francisco,...

Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution

Aclarion, a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain (cLBP), announced today the product release of Nociscan 2.6 which includes support for additional leading...

Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262

Sana Biotechnology, a company focused on changing the possible for patients through engineered cells, today announced the U.S. Food and Drug Administration (FDA) has cleared the company’s Investigational New Drug (IND) application to initiate a study of SC262 in patients with relapsed or refractory...

EndeavorRx, World’s First and Only Prescription Video Game Treatment, Secures FDA Label Expansion for Pediatric ADHD Patients Aged 13-17

Akili, a leading digital medicine company, today announced that it has received authorization from the U.S. Food and Drug Administration (FDA) to expand the label for EndeavorRx® from 8 to 12-year-old patients with primarily inattentive or combined-type ADHD who have a demonstrated attention issue...

BeeKeeperAI Expands Privacy-Enhancing Innovation with New Patent, New Product, and New Advantages to Accelerate Responsible AI in Healthcare

BeeKeeperAI, a pioneer in privacy-enhancing, multi-party collaboration software, today announced the next step in its innovation strategy for EscrowAI™ with automated, privacy-enhancing workflows to advance the responsible development and deployment of AI for healthcare. Dr. Michael Blum is the...